A framework for drug utilization evaluation in depression

Insights from outcomes research

Eric T. Edgell, Kent H. Summers, Timothy R. Hylan, Joseph Ober, J Lyle Bootman

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

BACKGROUND. Drug utilization evaluation (DUE) offers the prospect of improving the quality of care in depression by focusing on drug-related problems (DRPs). Outcomes research in depression can provide a basis on which to address difficulties in implementing DUE programs in the outpatient environment of managed care. OBJECTIVE. The purpose of this paper is to facilitate the development of a drug utilization evaluation program for depressed patients receiving care in an outpatient environment. METHODS. The literature was reviewed in the area of depression treatment, drug-related problems, and current outcomes research. This information was synthesized into a framework with potential DUE criteria. CONCLUSION. The quality of care for depression can be improved if these efforts are focused on solving DRPs. Outcomes research findings may be used as the basis for developing DUE criteria and as a first step in selecting and targeting interventions.

Original languageEnglish (US)
JournalMedical Care
Volume37
Issue number4 SUPPL. 1
StatePublished - Apr 1999

Fingerprint

Drug Utilization Review
utilization
Outcome Assessment (Health Care)
drug
evaluation
Quality of Health Care
Outpatients
Pharmaceutical Preparations
Managed Care Programs
Patient Care
managed care

Keywords

  • Antidepressant utilization
  • Drug utilization evaluation
  • Drug utilization review
  • Drug-related problems
  • Managed care
  • Quality assurance

ASJC Scopus subject areas

  • Nursing(all)
  • Public Health, Environmental and Occupational Health
  • Health(social science)
  • Health Professions(all)

Cite this

Edgell, E. T., Summers, K. H., Hylan, T. R., Ober, J., & Bootman, J. L. (1999). A framework for drug utilization evaluation in depression: Insights from outcomes research. Medical Care, 37(4 SUPPL. 1).

A framework for drug utilization evaluation in depression : Insights from outcomes research. / Edgell, Eric T.; Summers, Kent H.; Hylan, Timothy R.; Ober, Joseph; Bootman, J Lyle.

In: Medical Care, Vol. 37, No. 4 SUPPL. 1, 04.1999.

Research output: Contribution to journalArticle

Edgell, ET, Summers, KH, Hylan, TR, Ober, J & Bootman, JL 1999, 'A framework for drug utilization evaluation in depression: Insights from outcomes research', Medical Care, vol. 37, no. 4 SUPPL. 1.
Edgell, Eric T. ; Summers, Kent H. ; Hylan, Timothy R. ; Ober, Joseph ; Bootman, J Lyle. / A framework for drug utilization evaluation in depression : Insights from outcomes research. In: Medical Care. 1999 ; Vol. 37, No. 4 SUPPL. 1.
@article{b99db5afda3f4ec8b8edc6da55bdf164,
title = "A framework for drug utilization evaluation in depression: Insights from outcomes research",
abstract = "BACKGROUND. Drug utilization evaluation (DUE) offers the prospect of improving the quality of care in depression by focusing on drug-related problems (DRPs). Outcomes research in depression can provide a basis on which to address difficulties in implementing DUE programs in the outpatient environment of managed care. OBJECTIVE. The purpose of this paper is to facilitate the development of a drug utilization evaluation program for depressed patients receiving care in an outpatient environment. METHODS. The literature was reviewed in the area of depression treatment, drug-related problems, and current outcomes research. This information was synthesized into a framework with potential DUE criteria. CONCLUSION. The quality of care for depression can be improved if these efforts are focused on solving DRPs. Outcomes research findings may be used as the basis for developing DUE criteria and as a first step in selecting and targeting interventions.",
keywords = "Antidepressant utilization, Drug utilization evaluation, Drug utilization review, Drug-related problems, Managed care, Quality assurance",
author = "Edgell, {Eric T.} and Summers, {Kent H.} and Hylan, {Timothy R.} and Joseph Ober and Bootman, {J Lyle}",
year = "1999",
month = "4",
language = "English (US)",
volume = "37",
journal = "Medical Care",
issn = "0025-7079",
publisher = "Lippincott Williams and Wilkins",
number = "4 SUPPL. 1",

}

TY - JOUR

T1 - A framework for drug utilization evaluation in depression

T2 - Insights from outcomes research

AU - Edgell, Eric T.

AU - Summers, Kent H.

AU - Hylan, Timothy R.

AU - Ober, Joseph

AU - Bootman, J Lyle

PY - 1999/4

Y1 - 1999/4

N2 - BACKGROUND. Drug utilization evaluation (DUE) offers the prospect of improving the quality of care in depression by focusing on drug-related problems (DRPs). Outcomes research in depression can provide a basis on which to address difficulties in implementing DUE programs in the outpatient environment of managed care. OBJECTIVE. The purpose of this paper is to facilitate the development of a drug utilization evaluation program for depressed patients receiving care in an outpatient environment. METHODS. The literature was reviewed in the area of depression treatment, drug-related problems, and current outcomes research. This information was synthesized into a framework with potential DUE criteria. CONCLUSION. The quality of care for depression can be improved if these efforts are focused on solving DRPs. Outcomes research findings may be used as the basis for developing DUE criteria and as a first step in selecting and targeting interventions.

AB - BACKGROUND. Drug utilization evaluation (DUE) offers the prospect of improving the quality of care in depression by focusing on drug-related problems (DRPs). Outcomes research in depression can provide a basis on which to address difficulties in implementing DUE programs in the outpatient environment of managed care. OBJECTIVE. The purpose of this paper is to facilitate the development of a drug utilization evaluation program for depressed patients receiving care in an outpatient environment. METHODS. The literature was reviewed in the area of depression treatment, drug-related problems, and current outcomes research. This information was synthesized into a framework with potential DUE criteria. CONCLUSION. The quality of care for depression can be improved if these efforts are focused on solving DRPs. Outcomes research findings may be used as the basis for developing DUE criteria and as a first step in selecting and targeting interventions.

KW - Antidepressant utilization

KW - Drug utilization evaluation

KW - Drug utilization review

KW - Drug-related problems

KW - Managed care

KW - Quality assurance

UR - http://www.scopus.com/inward/record.url?scp=0033109797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033109797&partnerID=8YFLogxK

M3 - Article

VL - 37

JO - Medical Care

JF - Medical Care

SN - 0025-7079

IS - 4 SUPPL. 1

ER -